Founded in 2011 Abcore, Inc. is a privately held biotechnology company focused on generation of polyclonal, monoclonal, and recombinant antibodies and is the largest camelid facility in the United States. Abcore is a leader in antibody discovery using phage display and generating single domain antibodies. Abcore has worked with some of the largest pharmaceutical companies in the world on early stage drug development and antibody discovery. Abcore has built a robust antibody discovery platform which utilizes both naïve and immunized antibody libraries.